These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 23917098)

  • 21. [Spasticity and everyday life in multiple sclerosis].
    Donzé C; De Sèze J
    Rev Neurol (Paris); 2012 Apr; 168 Suppl 3():S51-6. PubMed ID: 22721365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical assessment, management, and rehabilitation of walking impairment in MS: an expert review.
    Soler B; Ramari C; Valet M; Dalgas U; Feys P
    Expert Rev Neurother; 2020 Aug; 20(8):875-886. PubMed ID: 32729742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance training improves gait kinematics in persons with multiple sclerosis.
    Gutierrez GM; Chow JW; Tillman MD; McCoy SC; Castellano V; White LJ
    Arch Phys Med Rehabil; 2005 Sep; 86(9):1824-9. PubMed ID: 16181949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of Functional Ambulation Performance Score as measurement of gait ability: review.
    Gouelle A
    J Rehabil Res Dev; 2014; 51(5):665-74. PubMed ID: 25333744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Energy cost of walking and its association with gait parameters, daily activity, and fatigue in persons with mild multiple sclerosis.
    Motl RW; Sandroff BM; Suh Y; Sosnoff JJ
    Neurorehabil Neural Repair; 2012 Oct; 26(8):1015-21. PubMed ID: 22466791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accelerometry in persons with multiple sclerosis: measurement of physical activity or walking mobility?
    Weikert M; Motl RW; Suh Y; McAuley E; Wynn D
    J Neurol Sci; 2010 Mar; 290(1-2):6-11. PubMed ID: 20060544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of dorsiflexor endurance exercises on foot drop secondary to multiple sclerosis: a pilot study.
    Mount J; Dacko S
    NeuroRehabilitation; 2006; 21(1):43-50. PubMed ID: 16720937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persons with multiple sclerosis show altered joint kinetics during walking after participating in elliptical exercise.
    Huisinga JM; Schmid KK; Filipi ML; Stergiou N
    J Appl Biomech; 2012 Jul; 28(3):249-57. PubMed ID: 21975419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Which walking capacity tests to use in multiple sclerosis? A multicentre study providing the basis for a core set.
    Gijbels D; Dalgas U; Romberg A; de Groot V; Bethoux F; Vaney C; Gebara B; Medina CS; Maamâgi H; Rasova K; de Noordhout BM; Knuts K; Feys P
    Mult Scler; 2012 Mar; 18(3):364-71. PubMed ID: 21952098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Self-reported walking ability in persons with chronic stroke and the relationship with gait performance tests.
    Brogårdh C; Flansbjer UB; Lexell J
    PM R; 2012 Oct; 4(10):734-8. PubMed ID: 22766045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gait abnormalities in multiple sclerosis: pathogenesis, evaluation, and advances in treatment.
    Cameron MH; Wagner JM
    Curr Neurol Neurosci Rep; 2011 Oct; 11(5):507-15. PubMed ID: 21779953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility of Restoring Walking in Multiple Sclerosis with Multichannel Implanted Electrical Stimulation.
    Selkirk SM; Kobetic R; Lombardo LM; Pinault G; Triolo RJ
    Am J Phys Med Rehabil; 2017 Sep; 96(9):e170-e172. PubMed ID: 28151761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assistive devices for ambulation.
    Edelstein JE
    Phys Med Rehabil Clin N Am; 2013 May; 24(2):291-303. PubMed ID: 23598264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of spasticity on kinematics of gait and muscular activation in people with Multiple Sclerosis.
    Pau M; Coghe G; Corona F; Marrosu MG; Cocco E
    J Neurol Sci; 2015 Nov; 358(1-2):339-44. PubMed ID: 26409825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reducing falls and improving mobility in multiple sclerosis.
    Sosnoff JJ; Sung J
    Expert Rev Neurother; 2015 Jun; 15(6):655-66. PubMed ID: 25973774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact on activities of daily living using a functional electrical stimulation device to improve dropped foot in people with multiple sclerosis, measured by the Canadian Occupational Performance Measure.
    Esnouf JE; Taylor PN; Mann GE; Barrett CL
    Mult Scler; 2010 Sep; 16(9):1141-7. PubMed ID: 20601398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of dalfampridine, a novel pharmacologic approach for treating walking impairment in multiple sclerosis.
    Blight AR; Henney HR; Cohen R
    Ann N Y Acad Sci; 2014 Nov; 1329():33-44. PubMed ID: 25154911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minimally important clinical difference of the Timed 25-Foot Walk Test: results from a randomized controlled trial in patients with multiple sclerosis.
    Coleman CI; Sobieraj DM; Marinucci LN
    Curr Med Res Opin; 2012 Jan; 28(1):49-56. PubMed ID: 22073939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using perceptive computing in multiple sclerosis - the Short Maximum Speed Walk test.
    Behrens J; Pfüller C; Mansow-Model S; Otte K; Paul F; Brandt AU
    J Neuroeng Rehabil; 2014 May; 11():89. PubMed ID: 24886525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A wearable sensor identifies alterations in community ambulation in multiple sclerosis: contributors to real-world gait quality and physical activity.
    Shema-Shiratzky S; Hillel I; Mirelman A; Regev K; Hsieh KL; Karni A; Devos H; Sosnoff JJ; Hausdorff JM
    J Neurol; 2020 Jul; 267(7):1912-1921. PubMed ID: 32166481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.